ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

New Cooperative Group Funded

September 30, 1977

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

NTP Board Gives Concept Approvals

December 4, 1981

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008